Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Polivka

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Science Translational Medicine|August 27, 2025
Immune response and clinical severity are shaped by skin-adapted <i>Staphylococcus aureus</i> in chronically infected patientsAnne Jamet, Xiali Fu, Céline Dietrich, et al.
Journal of the American Academy of Dermatology|September 29, 2024
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide studyClaire Guillemin, Nathalia Bellon, Marie Jachiet, et al.
Iscience|July 25, 2022
Neuropilin-1 cooperates with PD-1 in CD8<sup>+</sup> T cells predicting outcomes in melanoma patients treated with anti-PD1Julien Rossignol, Zakia Belaid, Guillemette Fouquet, et al.
Journal of Clinical Immunology|May 12, 2023
JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach StudyMarie-Louise Frémond, Marie Hully, Benjamin Fournier, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersJulien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
American Journal of Hematology|September 17, 2024
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurinMaël Heiblig, Clément Gourguechon, Philippe Guilpain, et al.
Haematologica|September 2, 2024
Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosisJulien Rossignol, Sophie Georgin-Lavialle, Danielle Canioni, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Science Translational Medicine|August 27, 2025
Immune response and clinical severity are shaped by skin-adapted <i>Staphylococcus aureus</i> in chronically infected patientsAnne Jamet, Xiali Fu, Céline Dietrich, et al.
Journal of the American Academy of Dermatology|September 29, 2024
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide studyClaire Guillemin, Nathalia Bellon, Marie Jachiet, et al.
Iscience|July 25, 2022
Neuropilin-1 cooperates with PD-1 in CD8<sup>+</sup> T cells predicting outcomes in melanoma patients treated with anti-PD1Julien Rossignol, Zakia Belaid, Guillemette Fouquet, et al.
Journal of Clinical Immunology|May 12, 2023
JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach StudyMarie-Louise Frémond, Marie Hully, Benjamin Fournier, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersJulien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
American Journal of Hematology|September 17, 2024
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurinMaël Heiblig, Clément Gourguechon, Philippe Guilpain, et al.
Haematologica|September 2, 2024
Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosisJulien Rossignol, Sophie Georgin-Lavialle, Danielle Canioni, et al.
Pageof 4